Monoclonal antibodies directed against Mycoplasma pneumoniae surface components were examined for their ability to block mycoplasma attachment to chicken erythrocytes. Purified preparations of antibodies which recognize the major mycoplasma ligand mediating cytadherence (protein P1, 165 Mycoplasma pneumoniae is the causative agent of primary atypical pneumonia. Mycoplasma adherence to respiratory tissues is well documented (7, 14) , and a trypsinsensitive adhesin protein, P1, mediates cytadherence based on biochemical, genetic, and ultrastructural studies (2, 5, 9, 10, 14) . However, the mechanism by which mycoplasmas bind to host cells is complex and may involve various accessory proteins (2, 11, 13, 14) . The availability of monoclonal antibodies which recognize a spectrum of mycoplasma epitopes would be useful in dissecting the biological functions of membrane proteins in the receptormediated attachment of M. pneumoniae to host cells. To generate a library of antibodies and to circumvent an observed immunodominance of P1, we used a novel immunization scheme involving a mutant of M. pneumoniae which lacks P1. In the present study several of the monoclonal antibodies were assessed for their role in mycoplasma cytadherence.
Mycoplasma pneumoniae is the causative agent of primary atypical pneumonia. Mycoplasma adherence to respiratory tissues is well documented (7, 14) , and a trypsinsensitive adhesin protein, P1, mediates cytadherence based on biochemical, genetic, and ultrastructural studies (2, 5, 9, 10, 14) . However, the mechanism by which mycoplasmas bind to host cells is complex and may involve various accessory proteins (2, 11, 13, 14) . The availability of monoclonal antibodies which recognize a spectrum of mycoplasma epitopes would be useful in dissecting the biological functions of membrane proteins in the receptormediated attachment of M. pneumoniae to host cells. To generate a library of antibodies and to circumvent an observed immunodominance of P1, we used a novel immunization scheme involving a mutant of M. pneumoniae which lacks P1. In the present study several of the monoclonal antibodies were assessed for their role in mycoplasma cytadherence.
MATERIALS AND METHODS
Mycoplasma strains and culture conditions. Virulent, hemadsorbing M. pneumoniae M129 was originally isolated from a patient with mycoplasma pneumonia (17) . Broth passage 16 of this isolate (M129-B16) was used in this study. The nonhemadsorbing M. pneumoniae mutant 22 , which is avirulent in the hamster model and lacks protein P1 plus three other virulence-associated proteins, arose spontaneously from the cloned hemadsorbing parent strain (6, 14) .
Cultures of wild-type and mutant mycoplasmas were grown in 32-oz. (ca. 960 ml) prescription bottles containing 70 ml of Hayflick medium (8) at 37°C for 72 h (until the phenol red pH indicator in the medium changed to orange). Glass-attached monolayers were washed four times with phosphatebuffered saline (PBS; pH 7.2), gently scraped off the surface with a rubber policeman, and collected by centrifugation (9,500 x g for 20 min). For certain experiments, mycoplasmas were intrinsically labeled with [35S]methionine as previously described (16) .
Immunization of mice. BALB/c female mice (3 to 6 weeks old) were used for all immunizations. Four protocols were used to obtain immune spleen cells for hybridoma fusions. For fusion H5, mice were injected intraperitoneally (i.p.) with 50 jig of M. pneumoniae B16 in saline on days 1 and 15.
The humoral immune response of the mice was monitored by an enzyme-linked immunosorbent assay (ELISA) (20, 24) and radioimmunoprecipitation (RIP) (16 (20, 24) .
Immunoglobulin isotyping of monoclonal antibody. Monoclonal antibodies were isotyped by ELISA as previously described (20) . (16) . Mycoplasmas were then washed three times with PBS and collected by gently scraping glass-attached organisms into 7 ml of PBS and centrifuging them at 10,000 x g for 15 min. The resulting pellet was resuspended in 1.5 ml of PBS and was gently passed three times through a 25-gauge needle and twice through a 27-gauge needle. Cultures were then centrifuged 90 s at 4,000 x g to pellet clumped mycoplasmas, and the supernatant was again passed through a 27-gauge needle and centrifuged as before. The final supernatant of approximately 109 organisms was diluted to a volume of 3 ml of PBS, and 100-,ul aliquots were added to silicone-treated microfuge tubes containing either 300 ,ul of PBS or PBS plus monoclonal antibody. Tubes were incubated at 37°C for 1 h on a rocking platform.
Fresh preparations of whole chicken blood (Granite, Bur- Swabs were air dried overnight and then suspended in 10% trichloroacetic acid for 20 min at 4°C, 5% trichloroacetic acid for 10 min at 4°C, and 95% ethyl alcohol for 10 min at 25°C. The swab tips were removed, placed in a counting vial, and dried for 1 h at 37°C, followed by the addition of 10 ml of Liquiscent for the determination of bound radioactivity.
RESULTS
Identification of monoclonal antibodies which recognize M. pneumoniae antigens. Hybridoma supernatants which demonstrated anti-M. pneumoniae activity by ELISA were examined in a soluble RIP assay. Representative clones resulting from five different fusions are presented in Table 1 . The majority (85%) of hybridomas generated from mice which were immunized and boosted with wild-type M. pneumoniae B16 (H5, H10, and H12 fusions) secreted monoclonal antibodies which precipitated a 165-kilodalton (kDa) protein. This protein, identified as protein P1, is a dominant immunogen during infection with M. pneumoniae as shown by biochemical and immunological criteria with the use of wild-type and mutant M. pneumoniae (11, 16) . In an attempt to circumvent the immunodominance of protein P1, mice were boosted 3 days before fusions (H13 and H19) with a mutant strain of M. pneumoniae which lacks P1 (14) . This immunization procedure resulted in production of monoclonal antibodies which recognized a variety of protein epitopes (Table 1) . In contrast to the hybridomas resulting from prior fusions, only 1 antibody-secreting clone of 31 RIP' H13 clones and 0 of 30 RIP' H19 clones precipitated P1. All monoclonal antibodies directed againt M. pneumoniae proteins were immunoglobulin G (IgG) or IgM isotypes. Monoclonal antibodies which recognized protein P1 were predominantly IgG2a. All antibodies used for attachment and metabolic inhibition studies were of the IgG isotype.
Monoclonal antibodies were analyzed by whole-cell and solubilized RIP to determine whether these antibodies recognized accessible epitopes on the surface of intact M. pneumoniae. In addition to anti-Pl monoclonal antibodies, examination of H13.4F4 and H19.20F6 clones revealed that their target epitopes (32-kDa and 110-kDa proteins, respectively) are also expressed on the surface of M. pneumoniae. In contrast, the epitope recognized by H13.1D11 (200 kDa) was not precipitated in a whole-cell RIP yet was detected in a soluble-antigen RIP, implying that this determinant is not surface accessible (data not shown).
The H13 fusion also generated hybridomas which secreted antibodies which were strongly positive by ELISA yet did not bind to protein determinants in the RIP. These antibodies have been shown to be specific for lipid antigens of M. pneumoniae (20) . Based upon thin-layer chromatographic separation of M. pneumoniae lipids, these antibodies were grouped into two categories. One category reacted with thin-layer chromatographic fractions 2, 3, and 7 (H13.2G2 and H13.17H9; see Table 4 ), and the other group reacted with fractions 2 through 7 (H13.11F10; see Table 4 ).
Inhibition of attachment of M. pneumoniae cells to RBC by monoclonal antibodies. Monoclonal antibodies which precipitated the 165-kDa protein P1 in the RIP were assayed (singularly or pooled) for the inhibition of the binding of M. pneumoniae to chicken RBC. H12.5B8 inhibited attachment by 90% or greater at concentrations of 10 to 300 ,ug per tube ( Table 2 ). All five anti-Pl monoclonal antibodies were similarly effective when assayed individually; pooled antibody preparations appeared less inhibitory.
Since the whole blood used in the attachment assay was composed of many cell types, some of which may readily bind the Fc region of antibody, assays were repeated with Ficoil-Hypaque-gradient-purified chicken RBC. The inhibition of mycoplasma attachment with the use of purified RBC was equivalent to that with whole blood (data not shown).
Other monoclonal antibodies were compared to determine their effectiveness in blocking the attachment of M. pneumoniae to chicken RBC (Table 3) . Monoclonal antibodies specific for cell surface protein epitopes other than P1 significantly blocked M. pneumoniae binding. Predictably, H13.1D1j which did not bind to a surface accessible epitope had little effect. Surprisingly, monoclonal antibodies reactive against lipid antigens of M. pneumoniae enhanced mycoplasma binding (Table 4 ). These data have been consistently reproducible for all anti-lipid antibodies tested.
To assure that the anti-M. pneumoniae lipid or protein antibodies were not nonspecifically binding via the Fc or Fab region, two experiments were performed. In one assay, chicken RBC ghost membrane preparations (19) were used as antigen in an ELISA. Whereas rabbit anti-chicken RBC IgG (Cooper Biomedical) gave a strong optical density reading (>2.000), none of the mycoplasma anti-lipid or anti-protein antibodies bound to the RBC membrane preparations (optical density s 0.080). In the other assay, chicken RBC were methanol fixed onto slides and examined with anti-M. pneumoniae monoclonal antibodies and fluorescence-conjugated anti-mouse IgG (Jackson Immunoresearch Labs, Avondale, Pa.). As previously observed, none of the anti-M. pneumoniae antibodies bound to the fixed chicken RBC. Additionally, mycoplasmas incubated for 1 h in the presence or absence of both anti-lipid and anti-protein monoclonal antibodies were titrated, and CFU were counted (14) . No variation in CFU was observed between the control (PBS only) and monoclonal antibody colonies.
Effects of monoclonal antibodies on M. pneumoniae metabolism.
[3H]thymidine uptake by M. pneumoniae was measured to determine whether the observed inhibition of binding could be due to an inhibition of metabolic activity by the monoclonal antibodies. Incubation times were chosen in an attempt to duplicate conditions of the attachment assay. As anticipated, minimal inhibition was observed when these monoclonal antibodies were screened in three separate assays (Table 5) (14) . Our data reinforce the importance of P1, demonstrating that monoclonal antibodies to the 165-kDa protein strongly inhibit attachment of mycoplasma to chicken RBC. Three anti-Pl monoclonal antibodies generated from separate fusions were assayed (Table 3) , and all inhibited attachment by greater than 85%. Competition for binding sites plus the dilution effect of pooling the purified antibody preparations most likely resulted in the observed decrease in blocking efficiency of the pooled anti-Pl preparations (Table 2) .
Interestingly, two other monoclonal antibody preparations (H13.4F4 and H19.20F6) reactive against non-Pl surface proteins inhibited mycoplasma attachment to RBC. It has been proposed that the attachment process may involve mobilization of several proteins to form multiprotein complexes (2, 14) . Analysis of class II mutants of M. pneumoniae B16 indicates that these mutants do not hemadsorb, are avirulent, and exhibit poor adhesion to hamster tracheal rings (14) . Although these mutants do possess surface protein P1, they are unable to densely cluster this ligand at the tip organelle, and they lack a unique protein which migrates at 32 kDa (3) . This same protein is precipitated in wild-type, virulent M. pneumoniae by antibody H13.4F4, which, as shown in this study, inhibited mycoplasma attachment to chicken RBC. One might conclude that this protein is directly involved in the attachment process. In repeated assays it was observed that the inhibition of attachment with the use of antibodies to the 110-and 32-kDa proteins required antibody excess. Antibodies to these two proteins had to be at a concentration of 100 ,ug per tube for inhibition to occur. This was in contrast to monoclonal antibody preparations against protein P1, whose titers could be determined below 10 ,ug per culture to observe the inhibition of cytadherence (Table 2 ). These data imply that inhibition may occur by more than one mechanism, one of which requires antibody excess and antigen saturation. Studies in progress involving other monoclonal antibodies to surface epitopes should aid in understanding this phenomenon.
Because monoclonal antibodies to the surface protein epitopes of M. pneumoniae appeared to block cytadherence, it was of interest to examine the effect of monoclonal antibodies to nonprotein surface determinants. Antibodies to lipid (glycolipid) determinants of M. pneumoniae (20) demonstrated an unexpected activity. Anti-lipid antibodies significantly increased mycoplasma attachment to RBC over that reflected in control values. Neither the anti-protein antibody preparations nor anti-M. pneumoniae immune rabbit serum demonstrated this unique property. Additionally, these anti-lipid monoclonal antibodies, as shown by ELISA and immunofluorescence, did not bind to a variety of eucaryotic cell preparations or RBC. False enhancement due to nonspecific agglutination of mycoplasmas was also discounted by a lack of variation in CFU compared in the presence and absence of monoclonal antibodies. It appears, therefore, that the anti-lipid monoclonal antibodies may facilitate the clustering or rearrangement of M. pneumoniae membrane proteins, some of which are directly involved in mycoplasma attachment. This is not unlikely, because the determinants of plasma membranes of various cell types can be cross-linked by appropriate ligands or antibodies so as to induce capping and membrane rearrangement (1, 22) . Ultrastructural studies should clarify this possibility.
DNA synthesis by M. pneumoniae was examined in the presence of specific antibodies to determine whether antibody binding might inhibit the metabolism of M. pneumoniae and thereby influence attachment. As shown in Table 5 , only antibody H19.20F6 caused a slight reduction in [3H]thymidine uptake.
Antibody probes directed against surface molecules of mycoplasmas or other pathogenic microorganisms may be helpful in understanding the specific roles of membrane components in cytadherence. However, the possibility exists that antigen-antibody complexes involving surface epitopes unrelated to attachment may perturb membrane integrity and polarity and directly or indirectly influence cytadherence. Thus, observations based upon antibodymediated effects on biological functions such as cytadherence should be interpreted with great caution.
